Urology Device Market Synopsis
Urology Device Market Size Was Valued at USD 253 Million in 2023, and is Projected to Reach USD 387 Million by 2032, Growing at a CAGR of 7.45 % From 2024-2032.
The urology device market concerns a broad array of medical devices utilized for extensive diagnosis, medical treatment, and control of urological diseases in the urinary tract, kidney, bladder, and male reproductive system. This market comprises equipment involving kidney stone extraction, UTI management, prostate conditions, incontinence, and treatments of bladder cancer. These products include catheters and catheter-associated devices such as urethral stents, dialysis equipment & services, endoscopes, robotic surgery systems, urinary drainage devices, and surgical instruments.
Urology device industries are on the rise because more people are developing kidney stones, prostate cancer, BPH, among other conditions, and people are aging, raising susceptibility to these diseases. At the same time, technological improvements in the minimally invasive surgical apparatuses, the increasing popularity of home health care equipment such as the dialysis system, and the increased healthcare industry infrastructure and technologies, especially in the developing regions, are driving the urology device market. With advancement in the diagnostic and therapeutic tools, the market has shown marked growth towards directed towards personalized treatment, integration of digital health, and efficient surgical instruments removing the urological ailments.
The urology device market has expanded over time due to rising prevalence of urological diseases including renal calculus, BPH, prostate cancer, UI and BC. These diseases associated with increased incidence with ageing and lifestyle factors have increased the need for diagnosis and treatment technologies. The market is vast and comprises several products, such as catheters, dialysis device, endoscopes, robotic surgeries, stents for the urethra used in the diagnosis and treatment of these ailments.

Urology Device Market Trend Analysis:
Increasing Adoption of Home Healthcare Solutions for Urology
-
The use of home care urology devices is gradually revealing itself as one of the major trends in the urology devices market due to the preference for home care, acceptable, cost-effective and improved quality of life. As technology progresses, telemedicine and home monitoring of CKD, BPH, UI patients or those with dialysis-dependent kidney failure have rapidly emerged as popular options for chronic urological care.
- Urology-based home healthcare solutions are the devices that include portable dialysis machines, urinary catheters, incontinence management products, and urine monitoring devices for urinary health conditions. It is helping to ease the pressure that healthcare facilities are experiencing, especially within the developing world where access to adequate care remains a highlighted challenge, and patient satisfaction as well as health outcome improvement is conferred through enhanced ability to self-manage chronic diseases within the comfort of home. Especially home dialysis has emerged as popular as patients can choose other options to complete in-center treatments, thereby limiting their movements to hospitals.
- In addition, home health has become more technologically advanced, with patients being able to receive constant watch from the doctors, together with feedback from them in case of any complications. Many smart devices like wrist wearable urology monitors, remote-controlled catheters, and internet-connected dialysis machines are nowadays able to monitor and transmit measurable health parameters and the information to doctors and other healthcare practitioners. Such integration of digital health solutions is assisting healthcare providers in monitoring patients’ status and progress, as well as modifying treatment options and intervening if needed, from a distance.
- As patients take more responsibility over their urological health needs this transformation is changing not only the enhanced patient satisfaction and prognosis but also easing the burden on hospitals and clinics. Home urology care is therefore likely to grow further with escalating healthcare costs and a more patient-centred, value-based care system.
Growing Healthcare Opportunities Driven by Aging Population
-
This coupled with an aging global population is also considered to be a main opportunity for the urology device market since individuals in the geriatric bracket are more vulnerable to develop a range of urological conditions. Some of conditions that are common to the elderly include benign prostatic hyperplasia, prostate cancer, urinary incontinence, kidney stones and bladder cancer. Such conditions usually necessitate chronic care medical procedures, operations, or even use of equipment for control or treatment. The increased ageing population notably in the developed world will ensure that urology devices that can meet this demographic’s needs will always be in high demand. For this reason, healthcare providers and manufacturers are currently targeting the production of devices that will suit the aging population needs such as catheters, dialysis, robotic surgical, and incontinence products.
- Besides, the ageing people are also having an extinct influence on the overall trends in healthcare delivery on devices. Because the elderly patients are generally affected by several co-existing diseases, the need for urological treatment that incorporates with other health services is increasing. This opens up a possibility of operative and non-hospital related treatments such as surgeries that do not require hospitalization, home health care services because elderlypreneurs prefer non-invasive treatments. Home dialysis systems and portable urology devices, for instance, are gaining market ground today because patients with analyzed diseases prefer to take care of their selves at home instead of constantly running back to the hospital.
- Telemedicine and remote patient monitoring have continuously been integrated into healthcare management systems to ensure effective control of elderly patients’ health. At the same time, this trend satisfies the demand of the ageing population for more accessible care as well as opens up a promising market for manufacturers of urology devices suitable for use in taking care of elderly patients.
Urology Device Market Segment Analysis:
Urology Device Market Segmented on the basis of type, application, end user, and
By Type, the Catheters segment is expected to dominate the market during the forecast period
-
The Catheters segment is likely to account for the largest market share in the urology device market throughout the forecast period because of the extensive use in the diagnosis, treatment and control of several urological diseases. Catheters are used as medical instruments in many applications, for instance, urinary, prostate diseases, hemodialysis, and lithotripsy. Hence, the increased popularity of easy-to-use, multifunctional devices, and the vital importance of CSDs for the treatment of chronic diseases like urinary retention or incontinence, and chronic renal failure are the major stimulators of the development of this segment. Moreover, innovations in catheter types available to the consumers include anti-microbial coated catheters, self-lubricated catheters, and biocompatible material catheters have tended to enhance the safety, patient comfort, hence increasing demand for the product.
- The increasing of aging global population, rising incidence of chronic kidney disease (CKD) and benign prostatic hyperplasia (BPH) all are driving the growth of catheters. For example, dialysis catheters are indispensable during the treatment of patients with end stage renal disease – ESRD, and urethral catheters are to be used in cases like urinary retention and dysfunction of bladder. They can be concluded that the catheters will remain in demand as the requirement for constant and efficient management of urological diseases increases. The catheters’ versatility in addressing minimal invasive procedures linked to various urological ailments also ensures the continuous growth of this segment, and thus, will remain the market leader in the urology device market over the forecast period.
By Application, Kidney Stones segment expected to held the largest share
-
The Kidney Stones segment is anticipated to occupy the largest market share of the urology device market throughout the forecast period due to increasing incidences of kidney stones across the globe and increased utilization of innovative methods of treating the same. Kidney stones which are quite common in the global population causes a lot of pain and health complications if they are not treated.
- An increase in the incidence of kidney stone diseases due to unhealthy dietary habits, lack of adequate water intake and physically inactive lifestyle stimulating the need for diagnostic instruments and therapeutic equipment including laser lithotripters, shock wave lithotripsy devices and ureteral stents. These devices are crucial for those procedures to break down and remove stones that are noninvasive and minimally invasive techniques to give the patient a short time to recover and might not develop complications compared to surgeries.
- The growth of this application is also being fueled by the increasing incidence of kidney stones, word-class technologies in treatment methods such as enhanced stone fragmentation technologies and better imaging systems. Several pulse care procedures like minor invasive one that include Percutaneous Nephrolithotomy (PCNL) and Ureteroscopy have been on the rise, which has as well enhanced the extent to which urology devices used in the treatment of Kidney stones are utilized.
- Also, the increasing knowledge of people in the chronic kidney disease (CKD) situation and the potential impact of renal failure are encouraging the detection of kidney stones. Being the largest segment in the urology device market, the increase in the prevalent of kidney stones and the ongoing search for efficient, minimally invasive treatment options supports steady growth in this segment throughout the forecast year.
Urology Device Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
North America is expected to have the largest market share of the urology devices market in the given period because of factors such as modern infrastructure of healthcare, high revenue on healthcare, and presence of main urology devices manufacturers. The United States alone has a huge pool of the aging population that is most likely to suffer from various urological diseases including BPH, kidney stones, prostate cancer and urinary incontinence.
- The increasing incidence of these diseases has led to the increased needs for Urology devices such as catheters, dialysis equipment, robotic surgical systems and endoscopes. Furthermore, the North American market stands to enjoy a rapid rate in the adoption of minimal-access surgical techniques; this has also boosted the market for innovative urological equipment and solutions.
- Technological factors such as advanced technologies in the healthcare setting and the incorporation of the digital health care solutions and robotic assisted surgeries also play the major role for the dominance of Asia-Pacific region. North America has experienced the first trends in using innovative urology devices like robotized assistance systems for prostate surgeries and smart catheters that improve patient’s comfort and health. Market development is similarly enhanced by higher personalized and patient-care oriented care in the region, along with sound and highly developed healthcare systems.
- In addition, good reimbursement policies and view access to various healthcare services and high level of healthcare spending in United States and Canada makes North America a crucial market of urology device. Therefore, the region is likely to retain its supremacy in the market, as advancement and growth are probably to prevail in the urology devices market within the coming period.
Active Key Players in the Urology Device Market
-
AbbVie Inc. (United States)
- Asahi Kasei Medical Co., Ltd. (Japan)
- B. Braun Melsungen AG (Germany)
- Boston Scientific Corporation (United States)
- ConvaTec Group PLC (United Kingdom)
- Cook Medical (United States)
- Dornier MedTech (Germany)
- Fresenius Medical Care AG & Co. KGaA (Germany)
- Hoya Corporation (Japan)
- Johnson & Johnson (United States)
- Karl Storz GmbH & Co. KG (Germany)
- Medline Industries, Inc. (United States)
- Medtronic PLC (Ireland)
- Olympus Corporation (Japan)
- Roche Diagnostics (Switzerland)
- Smith & Nephew (United Kingdom)
- Stryker Corporation (United States)
- Teleflex Incorporated (United States)
- Other Active Players
|
Global Urology Device Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 253 Million |
|
Forecast Period 2024-32 CAGR: |
7.45 % |
Market Size in 2032: |
USD 387 Million |
|
Segments Covered: |
By Type |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Urology Device Market by Type
4.1 Urology Device Market Snapshot and Growth Engine
4.2 Urology Device Market Overview
4.3 Catheters
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Catheters: Geographic Segmentation Analysis
4.4 Endoscopes
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Endoscopes: Geographic Segmentation Analysis
4.5 Dialysis Devices
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Dialysis Devices: Geographic Segmentation Analysis
4.6 Stents
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Stents: Geographic Segmentation Analysis
4.7 Robotic Surgery Systems
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Robotic Surgery Systems: Geographic Segmentation Analysis
4.8 Surgical Instruments
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Surgical Instruments: Geographic Segmentation Analysis
4.9 Other Devices.)
4.9.1 Introduction and Market Overview
4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.9.3 Key Market Trends, Growth Factors and Opportunities
4.9.4 Other Devices.): Geographic Segmentation Analysis
4.10
4.10.1 Introduction and Market Overview
4.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.10.3 Key Market Trends, Growth Factors and Opportunities
4.10.4 : Geographic Segmentation Analysis
Chapter 5: Urology Device Market by Application
5.1 Urology Device Market Snapshot and Growth Engine
5.2 Urology Device Market Overview
5.3 Kidney Stones
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Kidney Stones: Geographic Segmentation Analysis
5.4 Benign Prostatic Hyperplasia (BPH)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Benign Prostatic Hyperplasia (BPH): Geographic Segmentation Analysis
5.5 Urinary Incontinence
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Urinary Incontinence: Geographic Segmentation Analysis
5.6 Bladder Cancer
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Bladder Cancer: Geographic Segmentation Analysis
5.7 Prostate Cancer
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Prostate Cancer: Geographic Segmentation Analysis
5.8 Dialysis
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Dialysis: Geographic Segmentation Analysis
5.9 Other Applications)
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Other Applications): Geographic Segmentation Analysis
5.10
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 : Geographic Segmentation Analysis
Chapter 6: Urology Device Market by End User
6.1 Urology Device Market Snapshot and Growth Engine
6.2 Urology Device Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation Analysis
6.4 Ambulatory Surgical Centers (ASCs)
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Ambulatory Surgical Centers (ASCs): Geographic Segmentation Analysis
6.5 Dialysis Centers
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Dialysis Centers: Geographic Segmentation Analysis
6.6 Home Care Settings
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Home Care Settings: Geographic Segmentation Analysis
6.7 Pharmaceutical & Biotech Companies.)
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Pharmaceutical & Biotech Companies.) : Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Urology Device Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 MEDTRONIC PLC (IRELAND)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 BOSTON SCIENTIFIC CORPORATION (UNITED STATES)
7.4 JOHNSON & JOHNSON (UNITED STATES)
7.5 STRYKER CORPORATION (UNITED STATES)
7.6 B. BRAUN MELSUNGEN AG (GERMANY)
7.7 FRESENIUS MEDICAL CARE AG & CO. KGAA (GERMANY)
7.8 ABBVIE INC. (UNITED STATES)
7.9 OLYMPUS CORPORATION (JAPAN)
7.10 ROCHE DIAGNOSTICS (SWITZERLAND)
7.11 SMITH & NEPHEW (UNITED KINGDOM)
7.12 TELEFLEX INCORPORATED (UNITED STATES)
7.13 OTHER ACTIVE PLAYERS
Chapter 8: Global Urology Device Market By Region
8.1 Overview
8.2. North America Urology Device Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Type
8.2.4.1 Catheters
8.2.4.2 Endoscopes
8.2.4.3 Dialysis Devices
8.2.4.4 Stents
8.2.4.5 Robotic Surgery Systems
8.2.4.6 Surgical Instruments
8.2.4.7 Other Devices.)
8.2.4.8
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 Kidney Stones
8.2.5.2 Benign Prostatic Hyperplasia (BPH)
8.2.5.3 Urinary Incontinence
8.2.5.4 Bladder Cancer
8.2.5.5 Prostate Cancer
8.2.5.6 Dialysis
8.2.5.7 Other Applications)
8.2.5.8
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospitals
8.2.6.2 Ambulatory Surgical Centers (ASCs)
8.2.6.3 Dialysis Centers
8.2.6.4 Home Care Settings
8.2.6.5 Pharmaceutical & Biotech Companies.)
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Urology Device Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Type
8.3.4.1 Catheters
8.3.4.2 Endoscopes
8.3.4.3 Dialysis Devices
8.3.4.4 Stents
8.3.4.5 Robotic Surgery Systems
8.3.4.6 Surgical Instruments
8.3.4.7 Other Devices.)
8.3.4.8
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 Kidney Stones
8.3.5.2 Benign Prostatic Hyperplasia (BPH)
8.3.5.3 Urinary Incontinence
8.3.5.4 Bladder Cancer
8.3.5.5 Prostate Cancer
8.3.5.6 Dialysis
8.3.5.7 Other Applications)
8.3.5.8
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospitals
8.3.6.2 Ambulatory Surgical Centers (ASCs)
8.3.6.3 Dialysis Centers
8.3.6.4 Home Care Settings
8.3.6.5 Pharmaceutical & Biotech Companies.)
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Urology Device Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Type
8.4.4.1 Catheters
8.4.4.2 Endoscopes
8.4.4.3 Dialysis Devices
8.4.4.4 Stents
8.4.4.5 Robotic Surgery Systems
8.4.4.6 Surgical Instruments
8.4.4.7 Other Devices.)
8.4.4.8
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 Kidney Stones
8.4.5.2 Benign Prostatic Hyperplasia (BPH)
8.4.5.3 Urinary Incontinence
8.4.5.4 Bladder Cancer
8.4.5.5 Prostate Cancer
8.4.5.6 Dialysis
8.4.5.7 Other Applications)
8.4.5.8
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospitals
8.4.6.2 Ambulatory Surgical Centers (ASCs)
8.4.6.3 Dialysis Centers
8.4.6.4 Home Care Settings
8.4.6.5 Pharmaceutical & Biotech Companies.)
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Urology Device Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Type
8.5.4.1 Catheters
8.5.4.2 Endoscopes
8.5.4.3 Dialysis Devices
8.5.4.4 Stents
8.5.4.5 Robotic Surgery Systems
8.5.4.6 Surgical Instruments
8.5.4.7 Other Devices.)
8.5.4.8
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 Kidney Stones
8.5.5.2 Benign Prostatic Hyperplasia (BPH)
8.5.5.3 Urinary Incontinence
8.5.5.4 Bladder Cancer
8.5.5.5 Prostate Cancer
8.5.5.6 Dialysis
8.5.5.7 Other Applications)
8.5.5.8
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospitals
8.5.6.2 Ambulatory Surgical Centers (ASCs)
8.5.6.3 Dialysis Centers
8.5.6.4 Home Care Settings
8.5.6.5 Pharmaceutical & Biotech Companies.)
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Urology Device Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Type
8.6.4.1 Catheters
8.6.4.2 Endoscopes
8.6.4.3 Dialysis Devices
8.6.4.4 Stents
8.6.4.5 Robotic Surgery Systems
8.6.4.6 Surgical Instruments
8.6.4.7 Other Devices.)
8.6.4.8
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 Kidney Stones
8.6.5.2 Benign Prostatic Hyperplasia (BPH)
8.6.5.3 Urinary Incontinence
8.6.5.4 Bladder Cancer
8.6.5.5 Prostate Cancer
8.6.5.6 Dialysis
8.6.5.7 Other Applications)
8.6.5.8
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospitals
8.6.6.2 Ambulatory Surgical Centers (ASCs)
8.6.6.3 Dialysis Centers
8.6.6.4 Home Care Settings
8.6.6.5 Pharmaceutical & Biotech Companies.)
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Urology Device Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Type
8.7.4.1 Catheters
8.7.4.2 Endoscopes
8.7.4.3 Dialysis Devices
8.7.4.4 Stents
8.7.4.5 Robotic Surgery Systems
8.7.4.6 Surgical Instruments
8.7.4.7 Other Devices.)
8.7.4.8
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 Kidney Stones
8.7.5.2 Benign Prostatic Hyperplasia (BPH)
8.7.5.3 Urinary Incontinence
8.7.5.4 Bladder Cancer
8.7.5.5 Prostate Cancer
8.7.5.6 Dialysis
8.7.5.7 Other Applications)
8.7.5.8
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospitals
8.7.6.2 Ambulatory Surgical Centers (ASCs)
8.7.6.3 Dialysis Centers
8.7.6.4 Home Care Settings
8.7.6.5 Pharmaceutical & Biotech Companies.)
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Global Urology Device Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 253 Million |
|
Forecast Period 2024-32 CAGR: |
7.45 % |
Market Size in 2032: |
USD 387 Million |
|
Segments Covered: |
By Type |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||


